• English
  • Korean
  • Chinese
表紙
市場調査レポート - 239483

美顔術 (ボツリヌス毒素/皮膚充填剤):世界的なパイプライン分析、競合状況、2018年までの市場将来予測

Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData
出版日 ページ情報 英文 78 Pages
価格
美顔術 (ボツリヌス毒素/皮膚充填剤):世界的なパイプライン分析、競合状況、2018年までの市場将来予測 Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年04月25日 ページ情報: 英文 78 Pages
概要

当レポートでは、世界の美顔市場を国別/部門別に分析し、2011年の市場収益データと2018年までの将来予測、及び2011年の企業シェアデータを提供し、主な市場トレンド/発展・阻害要因を分析し、さらに主要市場プレーヤ/競合状況/主要パイプライン製品と技術についての情報も盛り込み、概略下記の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 手段の概要

  • ボツリヌス毒素
  • 皮膚充填剤

第4章 世界市場の特性化

  • 世界的予測収益 (2011-2018)
  • 主要トレンド
  • 市場動態

第5章 部門別分析

  • ボツリヌス毒素市場:世界的予測収益 (2011-2018)
  • ボツリヌス毒素市場:市場動態
  • 皮膚充填剤市場:世界的予測収益 (2011-2018)
  • 皮膚充填剤市場:市場動態

第6章 国別収益分析:2011-2018

  • 米国の予測収益 (2011-2018)
  • カナダの予測収益 (2011-2018)
  • 英国の予測収益 (2011-2018)
  • ドイツの予測収益 (2011-2018)
  • フランスの予測収益 (2011-2018)
  • イタリアの予測収益 (2011-2018)
  • スペインの予測収益 (2011-2018)
  • 日本の予測収益 (2011-2018)
  • 中国の予測収益 (2011-2018)
  • インドの予測収益 (2011-2018)
  • オーストラリアの予測収益 (2011-2018)
  • ブラジルの予測収益 (2011-2018)

第7章 戦略的競合評価

  • 世界の美顔市場:企業シェア (2011)
  • 世界のボツリヌス毒素市場:企業シェア (2011)
  • 世界の皮膚充填剤市場:企業シェア (2011)
  • 美顔市場の機会/リスク評価
  • 美顔市場の主要参入企業

第8章 戦略的パイプライン評価

  • 皮膚充填剤市場:世界のパイプライン製品リスト
  • 美顔市場におけるパイプライン製品のプロファイル
  • ボツリヌス毒素市場:世界のパイプライン製品リスト

第9章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global facial aesthetics market. It gives the market landscape, competitive landscape and market trends information for the facial aesthetics market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • The key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers).
  • Annualized market revenue data for 2011 and forecast forward to 2018, as well as company shares data for 2011. Company shares data for Botox and Dermal Fillers for 2011 are also provided.
  • Qualitative analysis of key market trends, market drivers, and restraints within the facial aesthetics market.
  • Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • The key players covered are Allergan, Q-Med, Mentor, Medicis and Merz.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the facial aesthetics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the facial aesthetics market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.

TOC

1 Table of Contents

1 Table of Contents 3

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 GlobalData Report Guidance 7

3 Facial Aesthetics - Device Overview 8

  • 3.1 Botulinum Toxin 8
  • 3.2 Dermal Fillers 8
    • 3.2.1 Hyaluronic Acid Based Dermal Fillers 8
    • 3.2.2 Other Dermal Fillers 9

4 Facial Aesthetics - Global Market Characterization 10

  • 4.1 Facial Aesthetics Market, Global, Revenue ($bn), Forecast, 2011-2018 10
  • 4.2 Facial Aesthetics Market, Key Trends 11
    • 4.2.1 Hyaluronic Acid Based Dermal Fillers to Drive the Market for Facial Aesthetics in the Future 11
    • 4.2.2 Inception of Hyaluronic Acid Based Dermal Fillers has led to the Decline of Collagen Products 11
  • 4.3 Facial Aesthetics, Market Dynamics 12
    • 4.3.1 Market Drivers 13
    • 4.3.2 Market Restraints 14

5 Facial Aesthetics Market - Segment Analysis 16

  • 5.1 Botulinum Toxin, Global, Revenue ($bn), Forecast, 2011-2018 16
  • 5.2 Botulinum Toxin, Market Dynamics 17
    • 5.2.1 Key Market Drivers: Increasing Number of Procedures and Reducing Price Trend 17
    • 5.2.2 Market Growth Restraints: High Side Effects Profile and Temporary Results of Botulinum Toxin 18
  • 5.3 Dermal Fillers, Global, Revenue ($m), Forecast, 2011-2018 19
  • 5.4 Dermal Fillers, Market Dynamics 20
    • 5.4.1 Market Drivers 20
    • 5.4.2 Market Restraint 21

6 Facial Aesthetics Market, by Country, 2011-2018 22

  • 6.1 Facial Aesthetics Market, the US, Revenue ($m), Forecast, 2011-2018 22
  • 6.2 Facial Aesthetics Market, Canada, Revenue ($m), Forecast, 2011-2018 24
  • 6.3 Facial Aesthetics Market, the UK, Revenue ($m), Forecast, 2011-2018 26
  • 6.4 Facial Aesthetics Market, Germany, Revenue ($m), Forecast, 2011-2018 28
  • 6.5 Facial Aesthetics Market, France, Revenue ($m), Forecast, 2011-2018 30
  • 6.6 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2011-2018 32
  • 6.7 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2011-2018 34
  • 6.8 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2011-2018 36
  • 6.9 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2011-2018 38
  • 6.10 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2011-2018 40
  • 6.11 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2011-2018 42
  • 6.12 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2011-2018 44

7 Global Facial Aesthetics Market - Strategic Competitive Assessment 46

  • 7.1 Facial Aesthetics Market, Global, Company Share (%), 2011 46
  • 7.2 Botulinum Toxin Market, Global, Company Share (%), 2011 47
  • 7.3 Dermal Fillers Market, Global, Company Share (%), 2011 48
  • 7.4 Facial Aesthetics, Market Opportunities and Risk Evaluation 50
    • 7.4.1 Opportunities 50
    • 7.4.2 Risks 51
  • 7.5 Facial Aesthetics Market, Key Market Participants 51
    • 7.5.1 Allergan, Inc 51
    • 7.5.2 Q-Med AB (Subsidiary of Galderma S.A.) 54
    • 7.5.3 Mentor Worldwide LLC (Subsidiary of Ethicon, Inc.) 56
    • 7.5.4 Medicis Pharmaceuticals Corporation 59
    • 7.5.5 Merz GmbH & Co. KGaA 60

8 Facial Aesthetics Market - Strategic Pipeline Assessment 64

  • 8.1 Dermal Fillers Market, List of Pipeline Products, Global, 2011 64
  • 8.2 Profiles of Pipeline Products in Facial Aesthetics Market 65
    • 8.2.1 Aeon Astron Corporation: Aeon Dermal Filler 65
    • 8.2.2 Contura International A/S: Aquamid 65
    • 8.2.3 Merz Pharma GmbH & Co. KgaA: Belotero Soft 65
    • 8.2.4 Mosaic Medical Technologies, Inc: Dermal Filler 66
    • 8.2.5 Allergan, Inc.: Juvederm Voluma 66
    • 8.2.6 Q-Med AB: Macrolane 66
    • 8.2.7 Q-Med AB: Restylane Touch 67
    • 8.2.8 EternoGen, LLC: Aesthetic Procedures 67
    • 8.2.9 Anika Therapeutics, Inc.: Next Generation Elevess Dermal Filler 67
    • 8.2.10 FibroGen, Inc. FG-5030 68
    • 8.2.11 Prollenium Medical Technologies, Inc: Revanesse Ultra 68
    • 8.2.12 TEI Biosciences Inc.: Injectable Dermal Fille 68
    • 8.2.13 Mentor Worldwide LLC: Puragen 69
    • 8.2.14 Mentor Worldwide LLC: Puragen Plus 69
    • 8.2.15 Teoxane laboratories: Teosyal Deep Lines 69
    • 8.2.16 Teoxane laboratories: Teosyal First Lines 70
    • 8.2.17 Teoxane laboratories: Teosyal Global Action 70
    • 8.2.18 Teoxane laboratories: Teosyal Kiss 70
    • 8.2.19 Teoxane laboratories: Teosyal Meso 71
    • 8.2.20 Teoxane laboratories: Teosyal Touch Up 71
    • 8.2.21 Teoxane laboratories: Teosyal Ultra Deep 71
  • 8.3 Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72
    • 8.3.1 Revance Therapeutics, Inc.: RT001 72
    • 8.3.2 Q-Med AB: Azzalure 72
    • 8.3.3 Johnson & Johnson: PurTox 73

9 Appendix 74

  • 9.1 Definitions 74
    • 9.1.1 Facial Aesthetics 74
  • 9.2 Acronyms 75
  • 9.3 Sources 75
  • 9.4 Research Methodology 76
  • 9.5 Secondary Research 76
  • 9.6 Primary Research 77
  • 9.7 Models 77
  • 9.8 Forecasts 77
  • 9.9 Expert Panels 78
  • 9.10 GlobalData Consulting 78
  • 9.11 Contact Us 78
  • 9.12 Disclaimer 78

List of Tables

1.1 List of Tables

  • Table 1: Facial Aesthetics Market, Global, Revenue ($bn), 2011-2018 10
  • Table 2: Collagen Products, The US, Number of Procedures (000's), 2000-2011 11
  • Table 3: Botulinum Toxin, Global, Revenue ($bn), 2011-2018 16
  • Table 4: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000-2011 17
  • Table 5: Dermal Fillers, Global, Revenue ($m), 2011-2018 19
  • Table 6: Dermal Fillers Market, The US, Number of Procedures (million), 2000-2011 20
  • Table 7: Facial Aesthetics Market, the US, Revenue ($m), 2011-2018 22
  • Table 8: Facial Aesthetics Market, the US, Procedures (million), 2011 23
  • Table 9: Facial Aesthetics Market, Canada, Revenue ($m), 2011-2018 24
  • Table 10: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25
  • Table 11: Facial Aesthetics Market, the UK, Revenue ($m), 2011-2018 26
  • Table 12: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27
  • Table 13: Facial Aesthetics Market, Germany, Revenue ($m), 2011-2018 28
  • Table 14: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29
  • Table 15: Facial Aesthetics Market, France, Revenue ($m), 2011-2018 30
  • Table 16: Facial Aesthetics Market, France, Procedures (000's), 2011 31
  • Table 17: Facial Aesthetics Market, Italy, Revenue ($m), 2011-2018 32
  • Table 18: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33
  • Table 19: Facial Aesthetics Market, Spain, Revenue ($m), 2011-2018 34
  • Table 20: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35
  • Table 21: Facial Aesthetics Market, Japan, Revenue ($m), 2011-2018 36
  • Table 22: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37
  • Table 23: Facial Aesthetics Market, China, Revenue ($m), 2011-2018 38
  • Table 24: Facial Aesthetics Market, China, Procedures (000's), 2011 39
  • Table 25: Facial Aesthetics Market, India, Revenue ($m), 2011-2018 40
  • Table 26: Facial Aesthetics Market, India, Procedures (000's), 2011 41
  • Table 27: Facial Aesthetics Market, Australia, Revenue ($m), 2011-2018 42
  • Table 28: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43
  • Table 29: Facial Aesthetics Market, Brazil, Revenue ($m), 2011-2018 44
  • Table 30: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45
  • Table 31: Facial Aesthetics Market, Global, Revenue by Company ($m), 2011 46
  • Table 32: Botulinum Toxin Market, Global, Revenue by Company ($m), 2011 47
  • Table 33: Dermal Fillers Market, Global, Revenue by Company ($m), 2011 48
  • Table 34: Allergan, Key Marketed Products, Applications, Features and Benefits, 2012 52
  • Table 35: Allergan Inc., Acquires Groupe Corneal Laboratories SA, 2007 53
  • Table 36: Q-Med AB, Key Marketed Products, Applications, Features and Benefits, 2012 54
  • Table 37: Galderma Acquires Q-Med AB, 2011 55
  • Table 38: Mentor Worldwide, Key Marketed Products, Applications, Features and Benefits, 2012 57
  • Table 39: Johnson & Johnson Acquires Mentor Corporation, 2009 57
  • Table 40: Medicis, Key Marketed Products, Applications, Features and Benefits, 2011 59
  • Table 41: Merz GmbH & Co. KGaA, Key Marketed Products, Applications, Features and Benefits, 2012 61
  • Table 42: Merz Pharma Completes The Acquisition of BioForm Medical, 2010 62
  • Table 43: Dermal Fillers Market, List of Pipeline Products, Global, 2011 64
  • Table 44: Aeon Dermal Filler, Product Status 65
  • Table 45: Aquamid, Product Status 65
  • Table 46: Belotero Soft, Product Status 65
  • Table 47: Dermal Filler, Product Status 66
  • Table 48: Juvederm Voluma, Product Status 66
  • Table 49: Macrolane, Product Status 66
  • Table 50: Restylane Touch, Product Status 67
  • Table 51: Dermal Filler - Aesthetic Procedures, Product Status 67
  • Table 52: Next Generation Elevess Dermal Filler, Product Status 67
  • Table 53: FG-5030, Product Status 68
  • Table 54: Revanesse Ultra, Product Status 68
  • Table 55: Injectable Dermal Filler, Product Status 68
  • Table 56: Puragen, Product Status 69
  • Table 57: Puragen Plus, Product Status 69
  • Table 58: Teosyal Deep Lines, Product Status 69
  • Table 59: Teosyal First Lines, Product Status 70
  • Table 60: Teosyal Global Action, Product Status 70
  • Table 61: Teosyal Kiss, Product Status 70
  • Table 62: Teosyal Meso, Product Status 71
  • Table 63: Teosyal Touch Up, Product Status 71
  • Table 64: Teosyal Ultra Deep, Product Status 71
  • Table 65: Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72
  • Table 66: RT001, Product Status 72
  • Table 67: Azzalure, Product Status 72
  • Table 68: PurTox, Product Status 73

List of Figures

1.2 List of Figures

  • Figure 1: Facial Aesthetics Market, Market Segmentation, 2012 8
  • Figure 2: Facial Aesthetics Market, Global, Revenue ($bn), 2011-2018 10
  • Figure 3: Collagen Products, The US, Number of Procedures (000's), 2000-2011 11
  • Figure 4: Facial Aesthetics, Market Dynamics 12
  • Figure 5: Botulinum Toxin, Global, Revenue ($bn), 2011-2018 16
  • Figure 6: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000-2011 17
  • Figure 7: Dermal Fillers, Global, Revenue ($m), 2011-2018 19
  • Figure 8: Dermal Fillers Market, The US, Number of Procedures (million), 2000-2011 20
  • Figure 9: Facial Aesthetics Market, the US, Revenue ($m), 2011-2018 22
  • Figure 10: Facial Aesthetics Market, the US, Procedures (million), 2011 23
  • Figure 11: Facial Aesthetics Market, Canada, Revenue ($m), 2011-2018 24
  • Figure 12: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25
  • Figure 13: Facial Aesthetics Market, the UK, Revenue ($m), 2011-2018 26
  • Figure 14: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27
  • Figure 15: Facial Aesthetics Market, Germany, Revenue ($m), 2011-2018 28
  • Figure 16: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29
  • Figure 17: Facial Aesthetics Market, France, Revenue ($m), 2011-2018 30
  • Figure 18: Facial Aesthetics Market, France, Procedures (000's), 2011 31
  • Figure 19: Facial Aesthetics Market, Italy, Revenue ($m), 2011-2018 32
  • Figure 20: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33
  • Figure 21: Facial Aesthetics Market, Spain, Revenue ($m), 2011-2018 34
  • Figure 22: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35
  • Figure 23: Facial Aesthetics Market, Japan, Revenue ($m), 2011-2018 36
  • Figure 24: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37
  • Figure 25: Facial Aesthetics Market, China, Revenue ($m), 2011-2018 38
  • Figure 26: Facial Aesthetics Market, China, Procedures (000's), 2011 39
  • Figure 27: Facial Aesthetics Market, India, Revenue ($m), 2011-2018 40
  • Figure 28: Facial Aesthetics Market, India, Procedures (000's), 2011 41
  • Figure 29: Facial Aesthetics Market, Australia, Revenue ($m), 2011-2018 42
  • Figure 30: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43
  • Figure 31: Facial Aesthetics Market, Brazil, Revenue ($m), 2011-2018 44
  • Figure 32: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45
  • Figure 33: Facial Aesthetics Market, Global, Company Share (%), 2011 46
  • Figure 34: Botulinum Toxin Market, Global, Company Share (%), 2011 47
  • Figure 35: Dermal Fillers Market, Global, Company Share (%), 2011 48
  • Figure 36: Botulinum Toxin Product Benchmarking 49
  • Figure 37: Hyaluronic Acid Based Dermal Fillers Product Benchmarking 49
  • Figure 38: Facial Aesthetics, Market Opportunities and Risk Evaluation, 2011 50
  • Table 39: Safety and Effectiveness of Juvederm Injectable Gel with Lidocaine 52
  • Figure 40: Allergan Inc., Internal Factor Analysis, 2012 53
  • Figure 41: Q-Med AB, Internal Factor Analysis, 2012 55
  • Table 42: Reduced Pain With Use Of Proprietary Hyaluronic Acid With Lidocaine For Correction Of Nasolabial Folds: A Patient-Blinded, Prospective, Randomized Controlled Trial 57
  • Figure 43: Mentor Worldwide, Internal Factor Analysis, 2012 58
  • Figure 44: Medicis Pharmaceutical Corporation, Internal Factor Analysis, 2012 60
  • Table 45: Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse Injectable Dermal Filler for the Treatment of Nasolabial Folds 61
  • Figure 46: Merz GmbH & Co. KGaA, Internal Factor Analysis, 2012 62
Back to Top